CBER updates two guides for staff on reviewing INDs and handling clinical holds
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesCBERCDERHealth Authority meeting and communication strategyPharmaceuticalsRegulatory Intelligence/PolicyRegulatory strategySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)